Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Global Bioinformatics Market (2022-2027) by Product & Service, Sector, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Bioinformatics Market is estimated to be USD 13.67 Bn in 2022 and is projected to reach USD 32.4 Bn by 2027, growing at a CAGR of 18.84%.
Market dynamics are forces that impact the prices and behaviors of the Global Bioinformatics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.
As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Agilent Technologies Inc, Beijing Genomics Institute (BGI), Biomax Informatics AG, Bio-Rad Laboratories, Biosystems Immunolab, etc.
Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Bioinformatics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Bioinformatics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Bioinformatics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Public-Private Sector Funding for Bioinformatics
4.1.2 Increasing Demand for Personalized Medicine
4.1.3 Increasing Pharmaceutical and Biotechnology R&D Expenditure
4.1.4 Decreasing Costs of Genome Sequencing
4.2 Restraints
4.2.1 High Equipment Costs
4.3 Opportunities
4.3.1 Adoption of Blockchain Technology and Cloud Computing
4.3.2 Integration of Machine Learning and AI in Healthcare
4.3.3 Investments by Leading IT Companies in the Development of Bioinformatics Solutions
4.4 Challenges
4.4.1 Management of Large Data Volumes
4.4.2 Lack of Interoperability and Multiplatform Capabilities
4.4.3 Growing Competition from In-House Development and Publicly Available Tools
4.4.4 Shortage of Skilled Bioinformatics Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Bioinformatics Market, By Product & Service
6.1 Introduction
6.2 Knowledge Management Tools
6.2.1 Generalized Knowledge Management Tools
6.2.2 Specialized Knowledge Management Tools
6.3 Bioinformatics Platforms
6.3.1 Data Analysis Platforms
6.3.2 Structural & Functional Analysis Platforms
6.3.3 Other Bioinformatics Platforms
6.4 Bioinformatics Services
6.4.1 Sequencing Services
6.4.2 Data Analysis Services
6.4.3 Drug Discovery Services
6.4.4 Differential Gene Expression Analysis Services
6.4.5 Database And Management Services
6.4.6 Other Bioinformatics Services
7 Global Bioinformatics Market, By Sector
7.1 Introduction
7.2 Medical Biotechnology
7.2.1 Drug Discovery & Development
7.2.2 Clinical Diagnostics & Personalized Medicine
7.2.3 Reproductive Health
7.3 Animal Biotechnology
7.4 Plant Biotechnology
7.5 Environmental Biotechnology
7.6 Forensic Biotechnology
7.7 Other Sectors
8 Global Bioinformatics Market, By Application
8.1 Introduction
8.2 Genomics
8.3 Chemoinformatics & Drug Design
8.4 Proteomics
8.5 Transcriptomics
8.6 Metabolomics
8.7 Other Applications
9 Americas' Global Bioinformatics Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe's Global Bioinformatics Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa's Global Bioinformatics Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC's Global Bioinformatics Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Agilent Technologies Inc
14.2 Beijing Genomics Institute (BGI)
14.3 Biomax Informatics AG
14.4 Bio-Rad Laboratories
14.5 Biosystems Immunolab
14.6 DNAnexus
14.7 DNASTAR
14.8 Eurofins Scientific
14.9 Fios Genomics
14.10 GeneData Inc
14.11 Genewiz
14.12 Genomatix GmbH
14.13 Illumina Inc
14.14 Jadbio
14.15 Microsynth
14.16 Neogenomics Laboratories
14.17 Partek
14.18 Perkin Elmer Inc
14.19 PetDx
14.20 Psomagen Inc
14.21 Qiagen NV
14.22 SOPHiA GENETICS
14.23 Source Bioscience
14.24 Thermo Fisher Scientific Inc
14.25 Waters Corp
15 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/er8j1s
Attachment
